{"id":"W2781921947","doi":"10.1016/j.jaad.2018.01.003","title":"Efficacy and safety of switching to ixekizumab in secukinumab nonresponders with plaque psoriasis: A multicenter retrospective study of interleukin 17A antagonist therapies","year":2018,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":54,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Secukinumab; Ixekizumab; Medicine; Interleukin 17; Psoriasis; Discontinuation; Psoriasis Area and Severity Index; Dermatology; Internal medicine; Dermatology Life Quality Index; Ustekinumab; Plaque psoriasis; Anakinra; Placebo; Adalimumab; Psoriatic arthritis; Alternative medicine; Cytokine; Pathology; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002199757,0.0003835804,0.0009380056,0.0005450854,0.0005370777,0.001070878,0.0004722227,0.0006754224,0.001101841],"category_scores_gemma":[0.003696109,0.0003899515,0.00148579,0.0008390528,0.0005644232,0.0007054469,0.0003082055,0.0008373572,0.0002525958],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005295832,"about_ca_system_score_gemma":0.0003901056,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001101944,"about_ca_topic_score_gemma":0.0006805994,"domain_scores_codex":[0.9978801,0.0007013517,0.0002976674,0.000580563,0.0002744155,0.000265979],"domain_scores_gemma":[0.9960263,0.0009429785,0.001713162,0.0005540292,0.000369762,0.0003938276],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01268759,0.0005296365,0.9792541,0.00003496316,0.0007920513,0.0002383167,0.0001818233,0.0001274557,0.001484761,0.00003527113,0.0001085141,0.004525443],"study_design_scores_gemma":[0.0006169057,0.004444777,0.9919961,0.00001328119,0.0007829521,0.000678787,0.0002589328,0.0003864,0.0004350374,0.00004184226,0.0003274784,0.0000175245],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9995728,0.0002082009,0.00002797222,0.000007856843,0.000003998465,0.000009670387,0.00005778102,0.000001239972,0.0001102907],"genre_scores_gemma":[0.9996847,0.00005087899,0.00002361532,0.00001997612,0.00001044976,0.000007530195,0.0001436037,0.000002032064,0.00005725975],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002199757,"threshold_uncertainty_score":0.01163357,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01177768967492962,"score_gpt":0.2791067948025814,"score_spread":0.2673291051276518,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}